JNJ-38518168

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for JNJ-38518168, covering 2013-03-04 to 2025-04-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent Asthma [Phase 2]